OncoDNA, the genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases, will customize its interpretation platform OncoKDM to make it compatible with SOPHiA GENETICS’ AI-powered SOPHiA DDM™ platform. The combined offering will enable the analysis and automatic translation of complex genomic data obtained via SOPHiA DDM™ into actionable recommendations, empowering[…]
The current health crisis has highlighted the resilience that Belgian companies have shown to accelerate research and allow the development, in record time, of multiple therapeutic solutions to counter the Covid-19 pandemic. This social responsibility is the proof of the value that an innovative biopharmaceutical industry could bring with its expertise in dealing with an epidemic.[…]
A first-round funding of 3 millions euros has been raised by Vésale Bioscience, the spin-out of the Vésale Pharma group which focuses on phagotherapy. In order to increase its financial resources and reach the stock market, the group has hired beLean.net Partner Guillaume de Viron as Head of Finance for the phage therapy division. Co-founder of Univercells, former CFO of MaSTHerCell,[…]
Vésale Bioscience has hired Guillaume de Viron, Partner at beLean.net, as Chief Financial Officer in order to accelerate its IPO. As CFO, Guillaume de Viron will contribute to Vésale Bioscience, which is currently preparing its fundraising (10+ million €) with the aim of accelerating the production and marketing of phages. Phage therapy is the use of phages,[…]
Pharmaceutical companies used to be eager buyers of technology. But in recent years, biotech platforms have benefited from easier access to capital as independent entities, eliminating the need to sell. At the same time, biopharma companies large and small are realizing that building a platform is better than focusing on a single product or production[…]
Thank you for attending the 3rd Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19 last Tuesday! We hope you enjoyed the event as much as we did and found the discussion and insight from our speakers relevant and interesting, looking at COVID-19 from a different angle and discovering potential lessons-learned to be[…]
Imcyse raises €21M and opens its capital to its new American partner, Pfizer. Very good news for the Liège-based biotech company Imcyse. Indeed, the biotech has developed an active immunotherapy technology that allows to tackle autoimmune diseases such as multiple sclerosis, type 1 diabetes or rheumatoid arthritis. A licensing agreement has just been signed with[…]
Registration is now open for the upcoming Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19, which we are co-organising with the European Brain Council on 27 April at 12:30-14:00. REGISTER NOW The last 14 months have been testing for global health. COVID-19 exposed weaknesses in public health systems’ preparedness to face pandemics and we continue to face[…]
The last 14 months have been a most testing time for the world in general and for global health in particular. COVID-19 took the world by surprise as weaknesses were exposed in public health systems’ preparedness to face pandemics and we continue to face the consequences over a year on. However, the emergence of COVID-19 has[…]
Listen to the latest edition of Brain Talks, a podcast series under the Brain Innovation Days umbrella Under the overarching theme, “Disrupt and rewire: How brain innovation is changing Europe”, the Brain Innovation Days aim to bring together key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem to create synergies and showcase the importance of[…]
Belgium and its companies at the forefront of the biotechnology industry in Europe Belgium is spearheading the European biotech industry. Meet some of the most successful cases of Belgian biotechnology companies. Belgium is one of the countries that provide the most to the biotech industry in Europe, as it has a total of more than[…]
We were excited to welcome you to the second digital session of the Brain Innovation Days last week – thank you for joining us! We would like to thank our excellent line-up of guest speakers representing the European Innovation Council, Roche, JLABS – Johnson & Jonhson Innovation, Brain+, Helpilepsy and EIT Health for their valuable insight. Furthermore, thank you to our 9 Pitch Competition[…]
The Brain Innovation Days hosted its first-ever Pitch Competition during the digital session on January 26. After careful analysis of over 90 applications from start-ups all over Europe, nine finalists went head-to-head to pitch their business in 180 seconds. PIPRA and icompanion were respectively crowned Jury and Public Awards for Best Pitch. Both win a free exhibition booth and free access to our physical event to be held in[…]
Did you know that the Brain Innovation Days will host its first-ever Pitch Competition during the upcoming digital session on 26 January? After careful analysis of over 90 applications from start-ups all over Europe, nine finalists will go head-to-head to pitch their business in 180 seconds for the chance to be crowned Best Pitch by a jury of highly regarded specialists in the fields of brain science, investment and start-up acceleration. DISCOVER THE[…]
Happy New Year, Brain Innovators! It’s officially 2021, which means we’re getting closer to the second Brain Innovation Days digital session. Registration is now open for the event to be held on 26 January 2021 at 12:30-14:30. This lunchtime interactive session will fall under the overarching theme, “From innovative ideas to creative brain interventions” and hosts the first ever Brain Innovation Days Pitch Competition, where nine start-ups will go head-to-head to pitch[…]
The Walloon Region Government to support the development of treatments at Novadip with 9.4M€ of non-dilutive funding Novadip Biosciences, a clinical-stage company developing treatments to regenerate damaged tissues in patients with significant unmet medical needs, has announced that the US Food and Drug Administration (FDA) has granted the designation of Rare Pediatric Disease and Orphan[…]
OUAT! recently raised 500k€ with the Innovation Fund. The capital infusion will support the further development of HakoBio and the roll out of the software to new clients. OUAT! aims to facilitate the digital transformation of the life sciences industry. In increasingly intelligent and connected factories, OUAT! enables the men and women of the biopharmaceutical industry to achieve[…]
Univercells Holding recently raises €70 million with two rounds of capital increase with new investors. The capital infusion will support the development of GMP facilities and the capacity to foster distributed manufacturing and supply of biologics. Univercells recently completed their Series C second close, bringing the total raised to €70 million. The financing, which was over-subscribed,[…]
The European Brain Council and beLean.net are pleased to invite you to the second Brain Innovation Days digital session, to be held on 26 January 2021 at 12:30-14:30. This lunchtime interactive session will fall under the theme Creative Brain Interventions and will host the first Brain Innovation Days Pitch Competition, where a number of start-ups will go head-to-head to pitch their business for the chance to win Best[…]
Many large investors have already set their sights on the Walloon company Univercells. Among them stands out the American billionaire George Soros; famous financier and philanthropist at the age of 90, Adjuvant Capital; a fund linked to the Bill Gates galaxy, the federal government through SFPI, and the Walloon government through SRIW. Bill Gates, as[…]